Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Markus Jerling Consulting is a small Swedish healthcare and life science consulting company focused on consultancy and training for the medicine and pharmaceutical industry. Public Swedish company registry aggregators describe the business as active and based in Bromma, Stockholm, with operations classified under healthcare services and consulting related to medicine and drug development. The company appears to operate primarily as a specialist advisory firm rather than as a therapeutic product developer, and there is no evidence of an internal drug pipeline, proprietary platform, or commercial pharmaceutical products. Available evidence suggests the firm is closely associated with Dr. Markus Jerling, an experienced clinical pharmacology and drug development executive who has also served as a consultant to biotech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Markus Jerling Consulting.